Background: Although there are considerable racial and ethnic disparities in prostate cancer incidence and mortality in the U.S. and globally, clinical trials often do not reflect disease incidence across racial and ethnic subgroups. This study aims to comprehensively review the reporting of race and ethnicity data and the representation of race an...
Synovial sarcoma is a rare cancer with peak incidence in the young adult period. Despite poor outcomes of this aggressive cancer, there is little epidemiologic research addressing its etiology. We collected birth characteristic data on synovial sarcoma cases born during 1978-2015 and diagnosed during 1988-2015 in California (n = 244), and 12,200 co...
The 16.9 million cancer survivors in the United States are at increased risk for comorbidities and recurrence. However, this risk may be attenuated by a healthy lifestyle. This study describes health behaviors by cancer history to inform behavior change priorities. We analyzed 2013-2017 data from the National Health Interview Survey. There were 164...
Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies with few known risk factors and biomarkers. Several blood protein biomarkers have been linked to PDAC in previous studies, but these studies have assessed only a limited number of biomarkers usually in small samples. In this study, we evaluated associations of...
Background: The four-kallikrein (4K) panel has been demonstrated to improve prediction of aggressive prostate cancer (PCa) compared to prostate-specific antigen (PSA) among men with moderately elevated PSA levels. However, the development and testing of the 4K panel has been conducted primarily in White men, with limited data in African Americans a...
Background The incidence of TGCT has been rising in the US and is notably higher among white men. Previously, our group reported that rates were rising among Hispanic men in certain areas. The present study sought to determine whether the patterns noted in our prior publication remained evident in more recent years and to determine whether any new ...
Background: HIV+ individuals are disproportionately at risk for HPV-associated cancers, but the magnitude of risk estimates varies widely. We conducted a retrospective study using a large United States-based cohort to describe the relationship between HIV infection and incident cervical, oropharyngeal, and anal cancers. Methods: Using 2001 – 2012 U...
Background: Colorectal cancer (CRC) incidence and mortality have declined with increased screening and scientific advances in treatment. However, improvement in CRC outcomes have not been equal for all groups and disparities have persisted over time. Methods: Data from the California Cancer Registry were used to estimate changes in 5-year CRC-speci...
The associations of abdominal skeletal muscle mass index (SMI), visceral and subcutaneous adipose tissue (VAT and SAT, respectively), and mortality among patients with stage I-III colorectal cancer may differ for men and women, but only few studies stratified their data into men and women. We investigated associations of abdominal SMI, VAT, and SAT...
Pancreatic cancer is the third leading cause of cancer death in the United States, and 80% of patients present with advanced, incurable disease. Risk markers for pancreatic cancer have been characterized, but combined models are not used clinically to identify individuals at high risk for the disease. Within a nested case-control study of 500 pancr...
